By Pat Anson, Editor
The day after the Food and Drug Administration said it would change the prescription guidelines for some opioid painkillers, millions of chronic pain patients and their physicians are still trying figure out who “won” the often bitter debate over the safety and long term effects of the drugs.
“I would call it a small victory,” said Dr. Andrew Kolodny, one of the founders of Physicians for Responsible Opioid Prescribing (PROP), which filed a citizens’ petition with the FDA last year demanding major changes in the labeling guidelines for painkillers to stop doctors from over-prescribing them.
“I think the new labeling will hopefully lead to extended release opioids being used as a last resort when all other options fail.”
On the other end of spectrum is Dr. Jeffrey Fudin, a vocal critic of PROP and its petition, who says the agency’s decision was a victory for pain patients — including many who worried they would lose access to pain medication.
“I feel sorry for the many patients nationwide that anguished day after day and sent thousands of anxiety stricken e-mails to politicians, the FDA, and to me. But they all owe this country and the FDA a debt of gratitude,” Fudin wrote in his blog.
Read more at National Pain Report.
(0) Readers Comments
November 12, 2012
October 08, 2012
September 12, 2012
July 23, 2012
June 11, 2019
April 05, 2019
April 01, 2019
March 18, 2019
Oh boy...Your right we hate to hear this. You know why people in pain
Doesn't the 1.5 billion is spent a year give credence to its possitive
Many MS drugs cause PML and deaths too these drugs all need t
I knew him when he was breaking in at a couple of Los Angeles TV stati
Saying there is a 'twist' is the worst type of spoile